Peter Zdziarski: A Brighter Future for Glanzmann Thrombasthenia Through Gene Therapy
Peter Zdziarski, Vice President and Marketing Director at Glanzmann’s Research Foundation, shared a post on LinkedIn։
“It’s Rare Disease Day, and tomorrow is the official Glanzmann Thrombasthenia Awareness Day.
I was born with GT, and knowing that I may see gene therapy in my lifetime is incredible.
Through every challenge and every win, I wouldn’t change my journey.
The people I’ve met, the knowledge I’ve gained, and the places this path has taken me have shaped who I am, and I’m truly grateful.
Please consider donating to the Medical College of Wisconsin.
Every contribution moves us closer to a future where people with GT have more than just a couple of treatment options.
But a true solution.
A future with fewer antibodies from platelet transfusions, fewer dangerous bleeds, less bruising, and fewer long hospital stays.
The future is bright.
Donate toward gene therapy.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 06:02Thomas Dayspring: Vascular Resilience – What Is It and How Can We Measure It?
-
Oct 19, 2026, 05:53Kevon Dindial: Collaboration for Better Childhood Cancer Outcomes
-
Oct 19, 2026, 05:44Mavis Agnes Kisakye: Raising Awareness about Haemophilia and Other Blood Disorders at Luweero General Hospital
-
Oct 19, 2026, 05:43Mohsen Asadi: Women and Blood Clots – Understanding Risk Across Every Life Stage
-
Oct 19, 2026, 05:39Shivir Moosai: Warm AIHA in a Young Woman
-
Oct 19, 2026, 03:54Jennifer Trowbridge: How Mutant Blood Stem Cells Use Inflammation to Drive Their Own Expansion
-
Oct 19, 2026, 03:39Wyenona Hicks: Catching Up With Old Friends and New Colleagues at AABB 2026
-
Oct 19, 2026, 03:33Developing a Non-Invasive Treatment for Life-Threatening PE – University of Michigan College of Engineering
-
Oct 19, 2026, 03:28Jim Hoffman: How NETs Contribute to Gallstone Formation and Growth